296 related articles for article (PubMed ID: 28096163)
1. Large-Scale Evaluation of
Thompson GR; Barker BM; Wiederhold NP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Cordeiro Rde A; Brilhante RS; Rocha MF; Medrano DJ; Monteiro AJ; Tavares JL; de Lima RA; de Camargo ZP; Sidrim JJ
Int J Antimicrob Agents; 2009 Sep; 34(3):278-80. PubMed ID: 19520551
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
7. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Skóra M; Bulanda M; Jagielski T
Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Chen TC; Chen YH; Chen YC; Lu PL
Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzon A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2006 Mar; 50(3):917-21. PubMed ID: 16495251
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Pfaller MA; Messer SA; Gee S; Joly S; Pujol C; Sullivan DJ; Coleman DC; Soll DR
J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
[TBL] [Abstract][Full Text] [Related]
18. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Feng P; Najafzadeh MJ; Sun J; Ahmed S; Xi L; de Hoog GS; Lai W; Lu C; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 Nov; 56(11):6044-7. PubMed ID: 22948876
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Chowdhary A; Hagen F; Curfs-Breuker I; Madrid H; de Hoog GS; Meis JF
Antimicrob Agents Chemother; 2015 Oct; 59(10):6642-5. PubMed ID: 26239995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]